Acrivon Therapeutics, Inc. (ACRV) vs PDS Biotechnology Corporation (PDSB)
- Acrivon Therapeutics, Inc. ACRV 1.64 −6.82%
- PDS Biotechnology Corporation PDSB 1.12 −13.85%
Acrivon Therapeutics, Inc. and PDS Biotechnology Corporation are both Biotechnology companies. Acrivon Therapeutics, Inc. and PDS Biotechnology Corporation are of similar size ($75.4M and $72.8M). Across the 8 metrics below, PDS Biotechnology Corporation leads on 5 and Acrivon Therapeutics, Inc. on 3.
Valuation
Profitability
| Metric | ACRV | PDSB | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 0.00% | 65.16% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | (64.63%) | (543.97%) | (56.36%) |
| Return on assets | (57.61%) | (136.65%) | (48.04%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack